Latest News

Access to Opioid Use Disorder Treatment Dependent on Insurance Status

Pregnancy and insurance status were significant barriers to obtaining appointments for opioid use disorder treatment.

Leveraging Machine Learning for Gut Microbiota-Based CVD Screening

Dysbiosis of the gut microbiota was identified in individuals with cardiovascular disease and modeled using machine learning.

Multichannel Smartwatch ECG vs Standard ECG for the Detection of ST-Segment Changes in ACS

Multichannel smartwatch ECG were found to be in agreement with standard ECGs for the detection of ST-segment changes in patients with acute coronary syndrome.

Fostering Trust Between Parents of Children With Cancer and Physicians

Although most parents of children with cancer form trusting relationships with their children’s oncologists, poor outcomes may negatively affect this.

High Asymptomatic COVID-19 Infection Rate Among Patients Treated With Biologics for Inflammatory Bowel Disease

Is treatment of inflammatory bowel disease (IBD) with biologic therapies harmful during infection with COVID-19?

Workplace Exposure to Toxic Substances Found to Be Associated With Abnormal Cardiac Structure and Function

Occupational exposures may be associated with abnormal echocardiographic measures of cardiac function and structure.

PARP Inhibitors Deemed Too Costly For Across-the-Board Frontline Maintenance in Ovarian Cancer

Broad use of PARP inhibitors to treat advanced-stage ovarian cancer would be associated with high costs compared with their biomarker-directed use.

Personalized IBS Treatment Associated With Symptom-Based Alterations to Gut Microbiota

Treatments guided by metagenomics may result in symptom improvement for patients with irritable bowel syndrome.

Permanent Hair Dye Not Linked to Cancer Risk, Mortality

Use of permanent hair dye is not associated with the risk for most cancers or cancer mortality.

FDA Cracks Down on Websites Illegally Selling Opioids

The unapproved and misbranded opioids, which include tramadol and oxycodone, are being sold without a prescription.

COVID-19: Influenza Vaccine Key in Mitigating Healthcare Burden During Flu Season

During the upcoming flu season, it is essential to ensure a high coverage rate of vaccination, particularly among populations who are vulnerable to COVID-19.

Phexxi, a Vaginal pH Regulator, Now Available for Pregnancy Prevention

Phexxi (lactic acid, citric acid and potassium bitartrate; Evofem Biosciences) is the first non-hormonal, on-demand contraceptive vaginal gel.

Financial Strain Tied to Higher Risk for Suicide Attempts

Financial strain is associated with an increased risk for suicide attempts and should be considered when assessing mental health.

Respiratory, Lung Cancer Death Up Even With Low-Intensity Smoking

Current low-intensity smokers have an increased risk for respiratory and lung cancer mortality.

Cannabis May Improve Quality of Life for IBD Patients

Although cannabis use does not induce clinical remission in IBD, patient-reported quality of life may improve.

Distribution and Spread of Susceptible and Resistant Gonorrhea in New York City

Isolates were clustered based on patient sexual behavior and race/ethnicity to assess antibiotic resistance as a major driver of gonorrhea transmission in NYC.

Challenges for Providing Psycho-Oncology Services During the Global Coronavirus Pandemic

A recent survey of UK psycho-oncology professionals highlighted the significant challenges and unexpected benefits experienced during the COVID-19 pandemic.

Concerns Among Patients Presenting for Drug Allergy Assessment

Patients in the United States who present to their physicians for drug allergy assessments have expressed concerns about their options for medical treatments, experiencing an allergic reaction, and seeking a diagnosis.

Updated CKD Nutrition Guideline Released

The newest KDOQI guideline for renal nutrition, which took 5 years to develop, expands recommendations to include patients with all stages of chronic kidney disease.

NAMS 2020 Genitourinary Syndrome of Menopause Position Statement Released

For patients with moderate to severe GSM, low-dose vaginal estrogens, vaginal DHEA inserts, systemic estrogen therapy, and ospemifene are recommended.